Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity

BACKGROUND: Rapamycin, an inhibitor of mammalian target of Rapamycin (mTOR), is an immunosuppressive agent that has anti-proliferative effects on some tumors. However, the role of Rapamycin-induced immune suppression on tumor progression has not been examined. METHODS: We developed a transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Svirshchevskaya, Elena V, Mariotti, Jacopo, Wright, Mollie H, Viskova, Natalia Y, Telford, William, Fowler, Daniel H, Varticovski, Lyuba
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453140/
https://www.ncbi.nlm.nih.gov/pubmed/18570671
http://dx.doi.org/10.1186/1471-2407-8-176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453140/
https://www.ncbi.nlm.nih.gov/pubmed/18570671
http://dx.doi.org/10.1186/1471-2407-8-176

Ejemplares similares